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a b s t r a c t
A DNA microarray was developed to detect plasmid-mediated antimicrobial resistance (AR) and viru-
lence factor (VF) genes in clinical isolates of Enterobacteriaceae and non-Enterobacteriaceae. The array
was validated with the following bacterial species: Escherichia coli (n=17); Klebsiella pneumoniae (n=3);
Enterobacter spp. (n=6);Acinetobactergenospecies 3 (n=1);Acinetobacter baumannii (n=1);Pseudomonas
aeruginosa (n=2); and Stenotrophomonas maltophilia (n=2). The AR gene proﬁles of these isolates were
identiﬁed by polymerase chain reaction (PCR). The DNA microarray consisted of 155 and 133 AR and
VF gene probes, respectively. Results were compared with the commercially available Identibac AMR-ve
Array Tube. Hybridisation results indicated that there was excellent correlation between PCR and array
results forARandVFgenes.Genes conferring resistance to eachantibiotic classwere identiﬁedby theDNA
array. Unusual resistance genes were also identiﬁed, such as blaSHV-5 in a blaOXA-23-positive carbapenem-
resistant A. baumannii. The phylogenetic group of each E. coli isolate was veriﬁed by the array. These
data demonstrate that it is possible to screen simultaneously for all important classes of mobile AR and
VF genes in Enterobacteriaceae and non-Enterobacteriaceae whilst also assigning a correct phylogenetic
group to E. coli isolates. Therefore, it is feasible to test clinical Gram-negative bacteria for all known AR
ortan
 genes and to provide imp
. Introduction
Levels of antimicrobial resistance in some developed coun-
ries are reaching crisis point, severely limiting treatment options
or an increasing number of nosocomially acquired infections [1].
apid and reliable identiﬁcation on nosocomial Gram-negative
athogens, along with characterisation of their resistance and
irulence mechanisms, are highly desirable for effective manage-
ent of infections. Early diagnosis and appropriate antimicrobial
reatment are essential to decrease the acquisition and spread of
ntimicrobial resistance (AR) and/or virulence factor (VF) genes
n these pathogens and thus improve patient survival and reduce
ealthcare costs [2].
∗ Corresponding author. Tel.: +353 1 896 3620; fax: +353 1 896 2131.
E-mail address: ﬁona1walsh@gmail.com (F. Walsh).
1 These authors contributed equally to this work.
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Open acct information regarding pathogenicity simultaneously.
© 2010 Elsevier B.V. and the International Society of Chemotherapy.
Identiﬁcation and characterisation of the genes responsible for
AR and virulence in Gram-negative pathogens have been typically
limited to gene-speciﬁcmultiplex polymerase chain reaction (PCR)
and sequencing. However, these methods have many common
drawbacks. They are both labour intensive and time consuming
and thus are not ideal for routine use in microbiology laborato-
ries. Moreover, they only screen for a relatively small number of
bacterial determinants, thereby overlooking numerous other AR
and VF genes that may be present. There is therefore a demand for
practical and cost-effective diagnostic methods that rapidly and
simultaneously detect all AR and VF genes in any given bacterial
strain.
Introduction of DNA microarray technology offers a viable
alternative. Oligonucleotide-based microarrays are generally con-
Open access under CC BY license.sidered to be more speciﬁc than PCR-based microarrays [3–7]. In
this study, we developed a customised glass slide oligonucleotide
microarray, called the enterobacterial resistance–virulence (ERV)
array. Recently, a commercialmicroarray has become available, the
Identibac AMR-veTM Array Tube (Veterinary Laboratories Agency,
ess under CC BY license.
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ddlestone, UK). This is amicrotubeDNAarray that detects up to 58
R genes of clinical importance in Salmonella spp. and Escherichia
oli. The aim of this study was to validate the capacity of the
ustomised ERV array to identify a representative collection of
osocomial Gram-negative pathogens and to detect all transfer-
ble AR and VF genes in these strains. The capacity of the Identibac
MR-ve Array Tube to detect all AR genes in these strains was also
nvestigated for comparison. Results of both microarray systems
erevalidatedbyPCRampliﬁcationand,wherenecessary, bydirect
equencing.
. Materials and methods
.1. Bacterial strains
This study employed 32 isolates, comprising 17 E. coli, 3 Kleb-
iella pneumoniae, 6 Enterobacter spp., 1Acinetobacter genospecies 3
nd 1 Acinetobacter baumannii, 2 Stenotrophomonasmaltophilia and
Pseudomonas aeruginosa. Isolates were recovered from blood cul-
ure, sputum, swab and urine samples from patients at St James’s
ospital (Dublin, Ireland) between 2004 and 2006.
.2. PCR detection of resistance genes
Enterobacteriaceae isolates were screened for the presence
f blaTEM, blaSHV, blaOXA, blaCTX-M, transferable ampC, aac(6′)-Ib-
r and qnr by PCR. Pseudomonas aeruginosa and Acinetobacter
pp. isolates were screened for the presence of blaVIM, blaIMP,
laSPM and blaGIM. Acinetobacter isolates were also screened
or blaOXA-23-like, blaOXA-24-like, blaOXA-51-like and blaOXA-58. Full-
ength PCR amplicons used for sequencing were generated using
able 1
esistance proﬁle of clinical isolates.
Isolate Resistance phenotype
AUG CTX CAZ
Escherichia coli 2004-1 S S S
E. coli 2004-8 S S S
E. coli 2004-23 R S S
E. coli 2004-49 R S S
E. coli 2004-69 R I R
E. coli 2004-62 R S S
E. coli 2005-1 S S S
E. coli 2005-13 R S R
E. coli 2005-19 R S S
E. coli 2005-72 I S S
E. coli 235663 R R R
E. coli 237088 R S S
E. coli 238727 R R S
E. coli 238728 R R S
E. coli 14815 R R R
E. coli 232227 R R R
E. coli 28265 R R R
Klebsiella pneumoniae 207.2 R R R
K. pneumoniae 234933 R S R
K. pneumoniae 26752 R S R
Enterobacter spp. 15584 R R R
Enterobacter spp. 235204 R R R
Enterobacter spp. 235797 R R R
Enterobacter spp. 236508 R R R
Enterobacter spp. 236878 R R R
Enterobacter spp. 32475 R R R
Acinetobacter genospecies 3 103165 – R S
Acinetobacter baumannii 229437 – R R
Pseudomonas aeruginosa 3 – – –
P. aeruginosa 53 – – –
Stenotrophomonas maltophilia 15251 R R R
S. maltophilia 89847 R R R
UG, Augmentin (amoxicillin/clavulanic acid); CTX, cefotaxime; CAZ, ceftazidime; ME
mikacin; GEN, gentamicin; NEG, negative; POS, positive; R, resistant; S, sensitive; I, inteimicrobial Agents 35 (2010) 593–598
PCR primers or primers designed to ﬂank the entire gene. Ten
E. coli isolates from blood cultures were screened for 15 VFs
associated with extraintestinal pathogenic E. coli pathogenesis
by PCR. Multiplex PCR ampliﬁcations employing three mark-
ers (chuA, yjaA and TSPE4.C2) allowed classiﬁcation of these
E. coli isolates into phylogenetic groups (A, B1, B2 or D). All
oligonucleotides employed in this study are available at http://
www.medicine.tcd.ie/clinical microbiology/research/oligos.php.
2.3. ERV oligonucleotide probe design and array construction
Generation of the custom ERV oligonucleotide probe-based
array and selection criteria of the geneswere as described by Cooke
et al. [8]. All target genes used to generate oligonucleotide probes
and their corresponding nucleotide accession numbers are docu-
mented in Supplementary Table 1.
2.4. Genomic DNA labelling and microarray hybridisation
Genomic DNA was extracted using the Archive Pure DNA
Cell/Tissue Kit (5PRIME, Hamburg, Germany) and labelled
with Cy3-dCTP using the BioPrime® DNA Labelling System
(Invitrogen–BioSciences Ltd., Dun Laoghaire, Ireland). After
labelling, probes were puriﬁed and applied to the microarray slide
as outlined previously [9]. Following incubation in a sealed humid
chamber at 42 ◦C for 16–24h, slides were washed twice in a series
of wash steps, dried and scanned immediately [9].2.5. Data analysis
DNA microarray slides were scanned using a GenePix® 4000B
scanner [Axon Instruments, MDS Analytical Technologies (GB) Ltd.,
MER ESBL CIP AMI GEN
S – S S S
S – S S S
S – R S S
S – R S S
S NEG R S S
S – S S S
S – S S S
S NEG S S R
S – R S S
S – S S S
S POS R S S
S NEG R S S
S POS R S S
S POS R S S
S POS R S R
S POS S S R
S POS R S R
R POS R S R
S NEG R S S
S NEG S S S
S POS R S R
S NEG R S S
S POS I S R
S POS R S S
S POS S S R
S NEG S S S
R – S S S
R – R R R
R – R S R
S – R S R
R – R R R
R – S R R
R, meropenem; ESBL, extended–spectrum –lactamase; CIP, ciproﬂoxacin; AMI,
rmediate.
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Table 2a
Comparison of the enterobacterial resistance–virulence (ERV) array hybridisation results and characterised polymerase chain reaction (PCR) proﬁles of Escherichia coli isolatesa.
E. coli
2004-
1
E. coli
2004-
8
E. coli
2004-
23
E. coli
2004-
49
E. coli
2004-
69
E. coli
2004-
62
E. coli
2005-
1
E. coli
2005-
13
E. coli
2005-
19
E. coli
2005-
72
E. coli
235663
E. coli
237088
E. coli
238727
E. coli
238728
E. coli
14815
E. coli
232227
E. coli
28265
Antimicrobial resistance gene element
blaTEM P P P P P P P P P P P P
M M M M M M M M M M M M M
blaSHV P
M
blaOXA P P
M M M
blaDHA PM
blaCTX-M P P P
M M M M M M
blaCMY P
M
Virulence factor gene element
chuA P P P P P P
M M M M M M M M M
yjaA P P P P P P P
M M M M M M M M M M M M M
TSPE4.C2 P P
M M M M M M M M
papA P P P P P
M M M M M M
papG allele I
M M M M M
papG allele II P P P P
M M M M
papG allele III P
sfa/focDE P P P
M M M M M
afa/draBC P
ﬁmH P P P P P P P P P
M M M M M M M M M M M M M M M M
hlyA P P P P
M M M M
cnf1 P P P
M M M
fyuA P P P P P P P
M M M M M M M M M M M M M M
iutA P P P P P P
M M M M M M M M M M M M M M M M
kpsMT II P P P P
M M M M M M M M
traT P P P P P
M M M M M M M M M M M
ibeA P
M
P, PCR-positive detection; M, microarray-positive detection.
a Only isolates with the sufﬁx 2004 and 2005 were analysed by PCR for the virulence determinants.
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okingham, UK]. A signal intensity value was quantiﬁed for each
uorescent DNA ‘spot’ and local background data on the microar-
ay using the GenePix Pro 6.1 software package. Hybridisation was
eemed positive when the median raw ﬂuorescence intensity for
ach spotwas >140 orwhen >50% of the pixels in the feature exhib-
ted a raw ﬂuorescence intensity greater than background levels
lus two standard deviations. These values were selected based
n analysis of known positive genes in control isolates. The raw
ata and ﬂag values were exported to GeneSpring GX 7.3 (Agilent
echnologies, Little Island, Cork, Ireland), where the median signal
alue from all viable replicate spots, per slide, was used for further
nalysis.
.6. Identibac AMR-ve Array Tube
The Identibac AMR-ve Array Tube was recently validated to
dentify AR genes (n=58) in Gram-negative bacteria, including
. coli and Salmonella [3]. Ampliﬁcation reactions, hybridisation,
ashing and scanning of the array tube were performed accord-
ng to the manufacturer’s instructions. Data normalisation, using
he ihfA control gene probe, and subsequent analysis was car-
ied out using IconoClust Software (AT-Version; CLONDIAG GmbH,
ena, Germany). The mean signal value for three replicate spots
er probe was used for analysis. Probes with intensity values of
0.4 were consider positive and those with intensity values of <0.3
ere considered negative, whilst those between 0.3 and <0.4 were
onsidered ambiguous.
. Results
.1. Detection and discrimination of antimicrobial resistance and
irulence factor genes with the ERV array
DNA from all isolates hybridised with between 5 and 39 AR
robes. The test group included isolates that were negative for all
enes investigated by PCR or were positive for only one gene. The
henotypic resistance proﬁle of all isolates is described in Table 1.
NA from E. coli isolates hybridised with between 10 and 80 of the
F probes. DNA from other isolates hybridised with between 1 and
3 VF probes. However, it must be noted that the VF probes were
esigned from E. coli and as such many would not necessarily be
resent in non-E. coli isolates.
.2. Correlation between PCR and ERV array hybridisation data
A good correlation was observed between the two methods for
laTEM, blaSHV, blaOXA, blaCMY and aac(6′)-Ib-cr AR genes (Tables 2a
nd 2b). The microarray was more sensitive in detecting blaTEM in
ne E. coli isolate and blaSHV in one K. pneumoniae isolate, which
ere negative by PCR. One Enterobacter isolate was positive for
laOXA by PCR and negative by microarray, but the opposite was
he case for one E. coli isolate.
Acinetobacter resistance genotypes showed 100% identity
etween the two methods in discrimination between A. bauman-
ii and Acinetobacter genospecies 3 using the presence of blaOXA-51
s a positive marker for A. baumannii identiﬁcation. Identiﬁca-
ion of blaOXA-51 in A. baumannii could also be used as a species
dentiﬁcation marker. However, blaOXA-27 was also identiﬁed in
oth isolates of Acinetobacter. One P. aeruginosa isolate was pos-
tive by PCR for blaVIM but was positive by microarray for blaSPM.
here were discrepancies between the PCR and microarray results
or the detection of blaDHA in K. pneumoniae and Enterobacter
pp.
Seven isolates were positive for blaCTX-M by microarray (CTX-
-9, n=4) and negative by PCR. Of these seven isolates, four were
henotypically conﬁrmed as extended-spectrum -lactamase Ta
b
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ESBL)-producers, a further two were resistant to cefotaxime and
eftazidime, and the ﬁnal isolate was susceptible to both antimi-
robials (Table 1). All isolates were negative for other ESBL genes.
he blaTEM genes identiﬁed in these isolates were blaTEM-1.
The blaCMY genewas detected by themicroarray and therewere
o false-positives. There was 100% correlation between the two
ethods with regards to aac(6′)-Ib-cr-positive isolates. Most of the
dditional isolates that were positive by microarray for aac(6′)-Ib
ere gentamicin-resistant. There was no correlation between the
wo methods for detecting qnr genes.
A good correlationwas also observed between the twomethods
or the 10 E. coli isolates that were screened for VF genes (Table 2a).
f the ﬁmbrial VFs screened for, there was a 100% correlation for
apA (n=5), papG allele II (n=4) and sfa/focDE (n=3). PCR was
ore sensitive in detecting papG allele III and afa/draBC, whilst the
icroarraywasmore sensitive in detecting ﬁmH. Amongst the ﬁm-
rial VFs screened, papG allele I gave the most varying correlations
etween the twomethods. It was detected in four E. coli isolates by
icroarray but not by PCR.
There was a 100% correlation between the two methods for
ll E. coli isolates that encoded hlyA (n=4) and cnf1 (n=3) toxin
enes, and also for traT (n=5) and ibeA (n=1) genes. The microar-
aywasmore sensitive indetecting fyuA and iutA siderophore genes
ompared with PCR (8 vs. 7 and 10 vs. 6 positives, respectively).
imilarly, the kpsMT II capsule biosynthesis gene was detected in
ix E. coli isolates by microarray but in four by PCR.
Nine E. coli isolates displayed a 100% correlation between the
wo methods with regards to classiﬁcation of phylogenetic group.
he microarray detected TSPE4.C2 in the ﬁnal isolate that was not
etected by PCR. However, because this isolate was also positive
or chuA and negative for yjaA, the presence or absence of TSPE4.C2
ould not have an overall effect on the phylogenetic group of
he isolate, since either way it would be classiﬁed as belonging to
roup D.
Whilst the number of VFs identiﬁed in the non-invasive E. coli is
reatly reduced comparedwith the bloodstream isolates, the over-
ll patterns of the main VFs within the E. coli isolated from urine,
wab and sputa samples corresponds to those identiﬁedwithin the
loodstream isolates. The urine isolates belonged to the phyloge-
etic groups A and B2, the swab isolate to group B2 and the sputum
solate to group B1.
.3. Identibac AMR-ve Array Tube
Eleven E. coli, two K. pneumoniae and ﬁve Enterobacter spp.
solates that were employed to validate the ERV array were
ubsequently analysed by the Identibac AMR-ve Array Tube for
omparison.
In total, nine E. coli isolates, two K. pneumoniae and four
nterobacter spp. and their duplicates generated successful hybridi-
ation results. The remaining isolates and their duplicates failed to
enerate successful hybridisation results and therefore were not
ncluded in further analysis. The Identibac array showed good cor-
elation with PCR results for the detection of -lactamases and
lasmid-mediated quinolone resistance determinants, except for
he detection of aac(6′)-Ib-cr genes. Overall, both of the microarray
ystems detectedmore AR genes comparedwith PCR ampliﬁcation
nalysis (Supplementary Table 2).
. DiscussionIn this study, we studied two microarray systems compared
ith conventional multiplex PCR methods, which rapidly provide
omprehensive information about the genotypic proﬁle of clinical
acterial isolates.microbial Agents 35 (2010) 593–598 597
The ERV array detected all blaTEM, blaSHV, blaOXA, blaCMY-2 and
aac(6′)-Ib-cr genes in all isolates. It also successfully classiﬁed
all 10 E. coli isolates into the correct phylogenetic group. Many
recent studies, particularly directed at E. coli bloodstream isolates,
have highlighted the importance of phylogenetic group analyses
in providing key information on mechanisms of pathogenesis and
levels of AR, and in highlighting strains with enhanced invasive
potentials as well as aiding epidemiological studies [10–12]. The
ERV array also correctly detected a high proportion of VFs, espe-
cially with probes that corresponded to the adhesin and toxin
genes.
Validationof this ERVarray is unique in that it also includednon-
Enterobacteriaceae. This demonstrates the lack of false-positive
cross-hybridisation between the plasmid resistance genes on the
array and any chromosomal genes in these bacteria. One of the
major advantages of screening isolates for all known AR genes is
the identiﬁcation of genes thatmay be co-located or co-transferred
on mobile elements. By screening the Acinetobacter spp. isolates in
this manner, we identiﬁed the presence of blaSHV-5 and aac(6′)-
Ib in both isolates. This is a similar resistance gene proﬁle to
an ESBL-producing A. baumannii in the USA that was suscepti-
ble only to colistin and rifampicin [13]. The difference is that
the carbapenem resistance in the isolates from our study could
be accounted for by the presence of blaOXA-23 carbapenemase
genes in both isolates. The microarray also detected a wide variety
of aminoglycoside, chloramphenicol, tetracycline and trimetho-
prim resistance genes in each species of Enterobacteriaceae. As
expected, few of these resistance genes were detected in the non-
Enterobacteriaceae.
Theoriginal validationstudyof the IdentibacAMR-veArrayTube
system reported 98.8% correlation between microarray and PCR
results, therefore verifying the high speciﬁcity of the microarray
probes [3]. However, the array was not able to detect resistance
genes in a number of isolates that were resistant to the aminogly-
cosides, -lactams, streptomycin, tetracycline, trimethoprim and
sulphonamides. Taking into account the number of discrepancies
reported by Batchelor et al. [3], some of which were also observed
in this study, it is possible that this array format needs to undergo
more stringent quality control checks, as there appears to be a high
degree of batch variability leading to misdetection of a number of
AR genes.
In conclusion, the ERV array proved more successful than the
Identibac AMR-ve Array Tube. It not only contains more AR probes
but also a comprehensive range of VF probes. There was a bet-
ter concordance between the genes detected by PCR, or with
their phenotypic results where PCR had not been performed, and
those detected by the ERV array hybridisations. Also, all ERV array
hybridisations successfully generated genotypic data using this
system, unlike the Identibac AMR-ve Array Tube. Another impor-
tant feature of the ERV array is that it is a very ﬂexible system.
It allows for future addition of supplemental target genes for fur-
ther AR and VF genes as they are identiﬁed and characterised.
Similarly, it allows for future reﬁnement by adding or removing
existing probes to improve the range, sensitivity and speciﬁcity.
Plasmid-mediated resistance transfer in non-Enterobacteriaceae
is an important factor in the proliferation and spread of antibi-
otic resistance in hospitals. Most microarray studies to date have
used E. coli and Salmonella spp. for validation. This study is
the ﬁrst to include non-Enterobacteriaceae for validation of the
array.
If the ERV array were to be combined with methodolo-
gies to amplify pathogen DNA directly from patient blood, this
would provide for a powerful and effective diagnostic tool. We
are currently examining whether whole-genome ampliﬁcation
methodologies such as OmniPlex may be suited to this aspiration
[14].
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